CSIMarket
Halozyme Therapeutics Inc   (HALO)
Other Ticker:  
 
 

Halozyme Therapeutics Inc 's Yearly EPS from Cont. Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



HALO Annual EPS from Cont. Operations Growth

2023
2022
2021
2020
2019
Y / Y Annual EPS from Cont. Operations Change 43.92 % -48.25 % 201.05 % - -
Annual EPS from Cont. Operations (in $) $2.13 $1.48 $2.86 $0.95 $-0.50


Annual EPS from Cont. Operations Growth Comment
Halozyme Therapeutics Inc 's Annual EPS from Cont. Operations for the fiscal year ended 2023, soared by 43.92% to $2.13, from $1.48 achieved a year ago. Halozyme Therapeutics Inc 's growrh rate for EPS from Cont. Operations improved from -48.25 % decline in the fiscal year 2022.

Halozyme Therapeutics Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2023 Annual EPS from Cont. Operations within Healthcare SectorY/Y EPS from Cont. Operations Growth %2023 Annual EPS from Cont. Operations
Moderna Inc